Physician profile
Dannie E Williams
NPI 1568626349
$4,682.16
in general payments reported to CMS, 2019-2025
27 companies · $265 in 2025
The $265 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,096 · 2020: $574 · 2021: $1,040 · 2022: $396 · 2023: $1,262 · 2024: $49.14 · 2025: $265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,537 · Education: $38.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,537.37 |
| Education | $38.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,019.80 | 2021-2025 | Vraylar, Qulipta, Ubrelvy |
| Otsuka America Pharmaceutical, INC. | $614.42 | 2020-2023 | Rexulti |
| Novo Nordisk INC | $569.09 | 2019-2023 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $431.79 | 2019-2024 | Mounjaro, Zepbound |
| Astrazeneca Pharmaceuticals LP | $354.64 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $197.14 | 2019-2023 | Trintellix |
| Pfizer INC. | $178.95 | 2019-2023 | |
| Biohaven Pharmaceuticals, INC. | $167.58 | 2021 | |
| Nestle Healthcare Nutrition INC. | $148.16 | 2020-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $145.41 | 2025 | |
| Allergan, INC. | $122.11 | 2019-2020 | |
| Astellas Pharma US INC | $96.39 | 2019-2020 | |
| Lundbeck LLC | $95.32 | 2021-2025 | Rexulti |
| Novartis Pharmaceuticals Corporation | $84.91 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $79.43 | 2020-2023 | Belsomra, Steglatro |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $77.85 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $51.70 | 2020-2021 | |
| Sentynl Therapeutics, INC. | $42.56 | 2019 | |
| Exact Sciences Corporation | $41.10 | 2025 | Cologuard Collection Kit |
| Sunovion Pharmaceuticals INC. | $27.51 | 2019 | |
| Collegium Pharmaceutical, INC. | $27.12 | 2020-2021 | |
| Upsher-Smith Laboratories LLC | $25.58 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $24.33 | 2022 | |
| Amgen INC. | $18.11 | 2020 | |
| Alfasigma USA, INC. | $17.49 | 2020 | |
| Redhill Biopharma INC. | $13.22 | 2020 | |
| Currax Pharmaceuticals LLC | $10.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dannie Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.